Valentines for Nerds
Check out our collection of biotech #nerdlove valentine cards on Pinterest.
The HER Pathway and Cancer
Dietmar Berger discusses the role of the HER2 receptor in metastatic breast cancer.
Array biopharma and Genentech's strategic alliance was voted Breakthrough Alliance of 2012. Partner with us.
How to Get Into the Brain
Learn how Genentech scientists developed a new way to get medicines through the blood-brain barrier.
Get to Know Us
How well do you know Genentech? Learn about who we are outside of the lab.
Request for Research Materials
We support investigators in academia by supplying key reagents. Request proteins, antibodies, and cDNAs.
Our people love working here, and it shows.
FORTUNE Best Company
We've been named to FORTUNE's "100 Best Companies to Work For" list for the 15th year in a row.
Rigorous and Groundbreaking Science
We're passionate about combatting the hardest-to-treat diseases. Learn about our research vision.
Jeff Settleman explains how biomarkers identify which patients may benefit from certain treatments.
A Patient-centric Approach
Here's how we put patients at the heart of everything we do.
The Genentech Research and Early Development pipeline has 30 new molecular entities in clinical development.
Meet our Scientists
Scientists are at the core of our business. Learn about what inspires them every day.
Taking Science Personally
Our scientists discuss their rigorous approach to breakthrough science.
The RAS-RAF Pathway
Chris Bowden explains the RAS-RAF pathway, an important and evolving area of cancer research.
Scientific Research Board
An advisory group to the company around research and early development projects.
Bay Area Top Employer
The San Francisco Business Times named us one of 2012's "Best Places to Work in the Bay Area."
Our immunology program offers the experience needed to transform knowledge into practice
Support for Scientific Projects
We provide funding for general research, translational research, and other development projects.